Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Celgene
 More »

  • JobWatch: Novartis Trims California Workforce
    ... Hart also cited BioNJ's Life Sciences Talent Network online job board. As of Wednesday, it featured dozens of positions from companies that include Celgene (35 jobs/all in-state), ...
    10-9-2013
  • Forma Achieves First Milestone in Celgene Collaboration
    Forma Therapeutics said today it earned its first milestone payment from Celgene for ... The size of the milestone payment was undisclosed. Celgene agreed to make up to $200 ...
    10-8-2013
  • GEN Reports on Downfall of a Once Biotech King
    The GEN interview with Blech can be found here . Blech, who played a key role in helping to start Genetic Systems, Celgene, Ariad Pharmaceuticals, Alexion Pharmaceuticals, and ...
    9-20-2013
  • Top 40 Molecular Millionaires
    ... 26 Closing price on February 26: $75.75 #13. Robert J. Hugin Chairman and CEO, Celgene Total value of all shares: $267,201,601 2,202,090 shares of common stock as of April ...
    9-19-2013
  • Empire Crumbles for a Once Biotech King
    ... The Blechs became famous on Wall Street, I was known as a whiz kid, and I had $30 million in the bank," he recounted. The Blechs also co-founded Celgene, a biopharmaceutical ...
    9-18-2013
  • Adimab Scores Two Deals and Some Milestone Payments
    and also Celgene and the receipt of milestone payments from existing collaborators. ... With Celgene, the partnership is broader. Adimab will generate therapeutic antibodies ...
    8-20-2013
  • The 20 Top Paid Women Executives in Biopharma
    ... Compensation: $1,645,473 % Change: 109.6% #10. Jacqualyn A. Fouse, Ph.D. Company: Celgene Title: EVP and CFO 2012 Compensation: $3,450,103 2011 Compensation: $2,535,033 % ...
    8-5-2013
  • Creative Acquisition in Biotech, Take Two
    Amgen, Gilead Sciences, Biogen Idec, Celgene, Vertex Pharmaceuticals, Regeneron ... Second, Celgene's acquisition of the former privately held Avila Therapeutics. Celgene was ...
    8-1-2013
  • What the Top 15 Biopharma CEOs Are Making
    1 % Change: 4.9% Position on 2012 List: Not ranked #14. Robert J. Hugin Company: Celgene Full title: CEO, President, and Chairman of the Board 2012 Compensation: $10,574,022 ...
    7-31-2013
  • Celgene Raises Acetylon Stake with Option to Buy for Potentially...
    Celgene agreed to advance development of Acetylon's lead product candidate and two of the ... said today, but which also gives Celgene an option to buy its collaboration partner. ...
    7-29-2013
  • Array, Celgene Enter Up to $387M R&D Pact Targeting Inflammation
    Array BioPharma and Celgene today announced having entered a collaboration through which ... Under the terms of the agreement, Celgene will pay Array $11 million up front, and will ...
    7-29-2013
  • Novo Nordisk Tops GEN List of Top 25 Biotech Companies
    Right behind Novo Nordisk is Amgen (NASDAQ:AMGN) with a $78.7 billion market cap, Gilead Sciences (NASDAQ:GILD) at $78.4 billion, Celgene (NASDAQ:CELG) coming in at $52.6 billion, ...
    7-25-2013
  • EFPIA, PhRMA: Trial Data-Sharing Benefits Patients, Scientists...
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA) this week jointly released principles ...
    7-25-2013
  • Clinical Trial Participation
    Clinical trials are absolutely necessary in order to make sure a drug works as intended. However, such testing does involve risk, as recently illustrated by Celgene's decision to ...
    7-18-2013
  • Celgene Halts a Phase III B-Cell CLL Trial Because of Deaths
    Celgene today said that after a consultation with the FDA it will stop administering ... treated with lenalidomide versus patients treated with chlorambucil," Celgene said. ...
    7-18-2013

  • Journal Articles

  • Immunomodulatory Drugs (IMiDs) Increase the Production of IL...
    Faribourz Payvandi, Lei Wu, Syedah D. Naziruddin, Maura Haley, Anastasia Parton, Peter H. Schafer, Roger S. Chen, George W. Muller, Christopher C.W. Hughes, David I. Stirling
    Journal of Interferon & Cytokine Research
    In the present study, we investigated the effects of one of the IMiDs, CC-4047 (Actimid(tm), Celgene, Warren, NJ), on synthesis of IL-2 protein and mRNA and on the activity and ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll